Elisabetta Metafuni
Overview
Explore the profile of Elisabetta Metafuni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Metafuni E, Brioschi F, Patriarca A, Leoni C, Battipaglia G, Carlino D, et al.
Br J Haematol
. 2025 Feb;
PMID: 39985320
In this study, we collected real-world evidence on the use of pegcetacoplan among 22 Italian patients with paroxysmal nocturnal haemoglobinuria showing suboptimal response to anti-C5 treatments eculizumab and ravulizumab. Most...
2.
Piccirillo N, Putzulu R, Fatone F, Massini G, Giammarco S, Metafuni E, et al.
Transfusion
. 2024 Dec;
65(1):159-169.
PMID: 39648279
Background: Extracorporeal photopheresis (ECP) has been demonstrated as an effective treatment for graft-versus-host disease (GvHD). The inline system was developed by Therakos in 1987. Recently, Fresenius Kabi implemented an integration...
3.
Giammarco S, Limongiello M, Di Marino L, Metafuni E, Teofili L, Chiusolo P, et al.
Bone Marrow Transplant
. 2024 Nov;
60(3):305-309.
PMID: 39567767
Pure red cell aplasia (PRCA) and autoimmune hemolytic anemia (AIHA) post-hematopoietic stem cell transplantation (HSCT) are an unmet medical need with no established standard of care, significantly affecting the patient...
4.
Frioni F, Metafuni E, Limongiello M, Piccirillo N, Massini G, Pellegrino C, et al.
Transfus Med Hemother
. 2024 Oct;
51(5):355-358.
PMID: 39371256
Introduction: Autoimmune hemolytic anemia (AIHA) occurs in 0.7-5.6% of patients undergoing hematopoietic stem cell transplantation, especially from unrelated or haploidentical donor or after lympho-depleted transplant; the majority of cases are...
5.
Sica S, Metafuni E, Frioni F, Limongiello M, Galli E, Sora F, et al.
Front Oncol
. 2024 Sep;
14:1387181.
PMID: 39234400
Introduction: Donor-specific antibodies (DSAs) correspond to anti-HLA antibodies of the recipient that are specifically directed to a mismatched antigen of the donor. In the setting of solid organ transplantation DSAs...
6.
Giammarco S, Chiusolo P, Maggi R, Rossi M, Minnella G, Metafuni E, et al.
Ann Hematol
. 2024 Aug;
103(10):3973-3977.
PMID: 39196375
Vitamin B12 deficiency is a common condition that causes a variety of disorders ranging from the development of megaloblastic anemia to the building up of neurological damage. Historically one of...
7.
Vergori A, Matusali G, Cimini E, Bordi L, Borrelli P, Lanini S, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066422
. We aimed to report the real-world use and outcomes over time in immunocompromised individuals receiving tixagevimab/cilgavimab (T/C) pre-exposure prophylaxis (PrEP). . This observational study included participants who received T/C...
8.
Spanjaart A, Ljungman P, Tridello G, Schwartz J, Martinez-Cibrian N, Barba P, et al.
Leukemia
. 2024 Jul;
38(9):1985-1991.
PMID: 39043963
COVID-19 has been associated with high mortality in patients treated with Chimeric Antigen Receptor (CAR) T-cell therapy for hematologic malignancies. Here, we investigated whether the outcome has improved over time...
9.
Metafuni E, Busnego Barreto M, Valentini C, Giammarco S, Limongiello M, Sora F, et al.
Front Oncol
. 2024 Jul;
14:1386670.
PMID: 39015495
Background: Pure red cell aplasia (PRCA) is a possible complication after allogeneic hematopoietic stem cell transplantation (HSCT) with major ABO incompatibility. Patients experience delayed engraftment of the erythroid series, with...
10.
Metafuni E, Carbone A, Petriccione L, Giammarco S, Limongiello M, Bellesi S, et al.
Blood Transfus
. 2024 Jul;
22(4):360-362.
PMID: 38949849
No abstract available.